IL17A and hepatocellular carcinoma: However, compared with those of HCC cells stimulated by IL‐17A and MK2206, the HCC cells treated with IL‐17A and IL‐6 mAb had low expression levels of E‐cadherin and ZO‐1 and high expression levels of N‐cadherin and vimentin.